Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: "B. Evans" Clear advanced filters

  • Dry age-related macular degeneration (AMD) is a major cause of vision loss in the elderly. Evans and Syed discuss the pipeline of therapies for dry AMD and the future of the market.

    • James B. Evans
    • Basharut A. Syed
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 12, P: 501-502

  • Products based on stem cells show promise in diverse therapeutic areas, including cardiovascular and autoimmune diseases. This article analyses the late-stage pipeline of stem cell therapies and provides a market overview.

    • Basharut A. Syed
    • James B. Evans
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 12, P: 185-186

  • The market for drugs to treat wet age-related macular degeneration (AMD) is expected to more than double by 2016. This article investigates unmet needs and discusses current agents in the pipeline.

    • Basharut A. Syed
    • James B. Evans
    • Leonard Bielory
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 11, P: 827